(Q36001964)

11 August 2017

1 reference

title

Gastric cancer: chemotherapy of advanced disease (English)

1 reference

11 August 2017

Macdonald JS

1

1 reference

11 August 2017

publication date

1 January 1992

1 reference

11 August 2017

published in

Hematological Oncology

1 reference

11 August 2017

volume

10

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

37-42

1 reference

A phase II trial of 5-fluorouracil and high-dose intravenous leucovorin in gastric carcinoma

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100108

7 January 2021

A phase II study of cisplatin in advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100108

7 January 2021

Comparison of oral ftorafur and intravenous 5-fluorouracil in patients with advanced cancer of the stomach, colon or rectum

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100108

7 January 2021

An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277)

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100108

7 January 2021

Chemotherapy of gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100108

7 January 2021

Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100108

7 January 2021

Bisantrene hydrochloride in gastric adenocarcinoma: a Southwest Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100108

7 January 2021

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100108

7 January 2021

Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100108

7 January 2021

Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100108

7 January 2021

An EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100108

7 January 2021

Identifiers

DOI

10.1002/HON.2900100108

1 reference

release_bbhkb5r43nglljzfdrzxe3s77y

11 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bbhkb5r43nglljzfdrzxe3s77y

24 November 2022

mapped directly with Wikidata item

1 reference